Mario Jolicoeur

9PUBLICATIONS
7CO-AUTHORS
Molecular targetsChemotherapyPredictive and prognostic markersMedical biochemistry - inorganic elements and compoundsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 27, 2024
Singlet Oxygen-Induced Mitochondrial Reset in Cancer: A Novel Approach for Ovarian Cancer Therapy.

Jorgelindo da Veiga Moreira, Laurent Schwartz, Mario Jolicoeur

|Oct 26, 2024
In Vitro Methylene Blue and Carboplatin Combination Triggers Ovarian Cancer Cells Death.

Jorgelindo da Veiga Moreira, Laurent Schwartz, Mario Jolicoeur

|Jan 23, 2024
Methylene Blue Metabolic Therapy Restrains In Vivo Ovarian Tumor Growth.

Jorgelindo da Veiga Moreira, Nancy Nleme, Laurent Schwartz

|Jun 02, 2021
Hyperosmolarity Triggers the Warburg Effect in Chinese Hamster Ovary Cells and Reveals a Reduced Mitochondria Horsepower.

Jorgelindo da Veiga Moreira, Lenny De Staercke, Pablo César Martínez-Basilio

|Jun 04, 2020
Restoration of Physiological Levels of Uric Acid and Ascorbic Acid Reroutes the Metabolism of Stored Red Blood Cells.

Manon Bardyn, Jingkui Chen, Michaël Dussiot

|Apr 17, 2020
Combining lipoic acid to methylene blue reduces the Warburg effect in CHO cells: From TCA cycle activation to enhancing monoclonal antibody production.

Léa Montégut, Pablo César Martínez-Basilio, Jorgelindo da Veiga Moreira

Pageof 2

Frequent Collaborators

5 joint publications

Jorgelindo da Veiga Moreira

1 joint publications

Manon Bardyn

1 joint publications

Michaël Dussiot

1 joint publications

Lucas Schmid